WASHINGTON,, ” January 27, 2025 / Prnewswire/-JPA Health, a crowned health innovation agency, proudly announces the launch of its Investor Relations (IR) practice, which offers customers in the pharmaceutical, biotechnological and medical equipment the opportunity to build stronger ties with The IR audience. Supported by the expertise of the agency in the field of data analysis and innovative approaches, this strategic expansion of JPA’s services underlines the use of the agency to offer comprehensive, customer-oriented solutions, including public relations, marketing, patient interests and medical communication.
The desk has selected Sarah McCABE lead the IR practice and report on Colleen CarterHead of life sciences. McCabe has served as a strategic partner for private and public life sciences companies in all development phases, from pre-clinical to commercial.
“Our model of synchronized specialists enables us to create tailor -made teams that can match the unique challenges of every customer,” said Carry JonesCEO. “Investor Relations was a missing piece of the puzzle for our Life Sciences offer, and we are happy that we can now offer this opportunity to support the success of our customers.”
Sarah is a seasoned manager and team leader with more than 20 years of experience. During her term of office at Stern Investor Relations, Sarah supplied tailor-made IR communication strategies and capital market advice, gathering a wealth of knowledge that will be of great importance in shaping the new practice of JPA.
“I am honored to join JPA Health, where our advanced data analysis and AI platforms offer insights to shape IR programs and to support decision-making that generates value for our customers,” said Sarah McCABESenior Vice-President Investor Relations. “The unique capacity of JPA to combine industry expertise with innovative technology enables us to develop strategies that deeply resonate with the biopharmaceutical community and beyond.”
JPA continues to take the lead in the field of innovation in the Life Sciences sector, supported by the recent acquisitions of True North Solutions, a data analysis company; Biocentric, an agency for medical communication; and Akt Health, based in London.
“Our strategic acquisitions increase our ability to deliver creative marketing, patient interests and business communation services of world class on a global scale,” said Colleen Carter. “The launch of our Investor Relations Practice also enables JPA to offer comprehensive solutions that meet the changing needs of our customers within Life Sciences and Health Tech & Services.”
JPA health
PPV Health is a crowned, independent, full-service agency, founded in 2007. With offices spread all over the world US And Great Britain brings the agency flexible solutions together in the field of public relations, commercial marketing, patient interests and medical communication Life Sciences, Health Tech & Services, Federal Government and Public Health. By using tailor-made AI solutions, PPV Develops seamless, 360-degree strategies to effectively involve stakeholders in health care. As one women-property,, “ Independent agency, we have a passion for helping people to live healthier and are committed to pushing the boundaries of healthcare communication. Discover more www.jpa.com.
Source PPV Health